PERK inhibition attenuates vascular remodeling and may alleviate pulmonary arterial hypertension caused by BMPR2 mutations.
Does PERK inhibition attenuate vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation?
Inhibiting the PERK arm of the unfolded protein response may alleviate pulmonary arterial hypertension caused by BMPR2 mutation.
Absolute Event Rate: 0% vs 0%
Inhibiting the PERK arm of the unfolded protein response may alleviate pulmonary arterial hypertension.
Shimizu et al. (Tue,) reported a other. PERK inhibition attenuates vascular remodeling and may alleviate pulmonary arterial hypertension caused by BMPR2 mutations.